New Search

Your search found 45 records, sorted by year and then date of acquisition.

1. Protocol Information: CTN-0030-A-3 - Protocol Amendment to Examine Long-Term Outcomes doc type
  CTN Dissemination Library protocol page
 
2. Protocol Information: CTN-0030-A-2 - Effects of Chronic Opioids on the Brain doc type
  CTN Dissemination Library protocol page
 
3. Protocol Information: CTN-0030-A-1 - Collection of Economic Data for the Prescription Opioid Addiction Treatment Study doc type
  CTN Dissemination Library protocol page
 
4. Protocol Information: CTN-0030 - Prescription Opioid Addiction Treatment Study (POATS) doc type
  CTN Dissemination Library protocol page
 
5. The Prescription Opioid Addiction Treatment Study: What Have We Learned. doc type
  Weiss, Roger D. ; Rao, Vinod
 Drug and Alcohol Dependence 2017;173:S48-S54. [doi: 10.1016/j.drugalcdep.2016.12.001].
 
6. Volatility and Change in Chronic Pain Severity Predict Outcomes of Treatment for Prescription Opioid Addiction. doc type
  Worley, Matthew J. ; Heinzerling, Keith G. ; Shoptaw, Steven ; Ling, Walter
 Addiction 2017;112(7):1202-1209. [doi: 10.1111/add.13782].
 
7. The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review. doc type
  Carroll, Kathleen M. ; Weiss, Roger D.
 American Journal of Psychiatry 2017;174(8):738-747. [doi: 10.1176/appi.ajp.2016.16070792].
 
8. Longitudinal Association Between Pain Severity and Subsequent Opioid Use in Prescription Opioid Dependent Patients with Chronic Pain. doc type
  Griffin, Margaret L. ; McDermott, Katherine A. ; McHugh, R. Kathryn ; Fitzmaurice, Garrett M. ; Jamison, Robert N. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2016;163(1):216-221. [doi: 10.1016/j.drugalcdep.2016.04.023].
 
9. Pain Volatility and Prescription Opioid Addiction Treatment Outcomes in Patients With Chronic Pain. doc type
  Worley, Matthew J. ; Heinzerling, Keith G. ; Shoptaw, Steven ; Ling, Walter
 Experimental and Clinical Psychopharmacology 2015;23(6):428-435. [doi: 10.1037/pha0000039].
 
10. Using Behavioral Economics to Predict Outcomes of Medication and Counseling for Prescription Opioid Dependence. doc type
  Worley, Matthew J. ; Shoptaw, Steven ; Bickel, Warren K. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Phoenix, AZ, June 13-18, 2015.
 
11. Health-Related Quality of Life Among Prescription Opioid-Dependent Patients: Results from a Multi-Site Study. doc type
  Griffin, Margaret L. ; Bennett, Heather E. ; Fitzmaurice, Garrett M. ; Hill, Kevin P. ; Provost, Scott E. ; Weiss, Roger D.
 American Journal on Addictions 2015;24(4):308-314. [doi: 10.1111/ajad.12188].
 
12. Long-term Outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; Provost, Scott E. ; Fitzmaurice, Garrett M. ; McDermott, Katherine A. ; Srisarajivakul, Emily N. ; Dodd, Dorian R. ; Dreifuss, Jessica A. ; McHugh, R. Kathryn ; Carroll, Kathleen M.
 Drug and Alcohol Dependence 2015;150:112-119. [doi: 10.1016/j.drugalcdep.2015.02.030].
 
13. Opioid Withdrawal, Craving, and Use During and After Outpatient Buprenorphine Stabilization and Taper: A Discrete Survival and Growth Mixture Model. doc type
  Northrup, Thomas F. ; Stotts, Angela L. ; Green, Charles ; Potter, Jennifer Sharpe ; Marino, Elise N. ; Walker, N. Robrina ; Weiss, Roger D. ; Trivedi, Madhukar H.
 Addictive Behaviors 2015;41:20-28. [doi: 10.1016/j.addbeh.2014.09.021].
 
14. Denial of Urinalysis-Confirmed Opioid Use in Prescription Opioid Dependence. doc type
  Hilario, E. Yvette ; Griffin, Margaret L. ; McHugh, R. Kathryn ; McDermott, Katherine A. ; Connery, Hilary Smith ; Fitzmaurice, Garrett M. ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2015;48(1):85-90. [doi: 10.1016/j.jsat.2014.07.003].
 
15. The Multi-Site Prescription Opioid Addiction Treatment Study: 18-Month Outcomes. doc type
  Potter, Jennifer Sharpe ; Dreifuss, Jessica A. ; Marino, Elise N. ; Provost, Scott E. ; Dodd, Dorian R. ; Rice, Lindsay S. ; Fitzmaurice, Garrett M. ; Griffin, Margaret L. ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2015;48(1):62-69. [doi: 10.1016/j.jsat.2014.07.009].
 
16. Initial Response as a Predictor of 12-Week Buprenorphine-Naloxone Treatment Response in a Prescription Opioid-Dependent Population. doc type
  McDermott, Katherine A. ; Griffin, Margaret L. ; Connery, Hilary Smith ; Hilario, E. Yvette ; Fiellin, David A. ; Fitzmaurice, Garrett M. ; Weiss, Roger D.
 Journal of Clinical Psychiatry 2015;76(2):189-194. [doi: 10.4088/JCP.14m09096].
 
17. Using Behavioral Economics to Predict Opioid Use During Prescription Opioid Dependence Treatment. doc type
  Worley, Matthew J. ; Shoptaw, Steven J. ; Bickel, Warren K. ; Ling, Walter
 Drug and Alcohol Dependence 2015;148:62-68. [doi: 10.1016/j.drugalcdep.2014.12.018].
 
18. Assessing Craving and Its Relationship to Subsequent Prescription Opioid Use Among Treatment-Seeking Prescription Opioid Dependent Patients. doc type
  McHugh, R. Kathryn ; Fitzmaurice, Garrett M. ; Carroll, Kathleen M. ; Griffin, Margaret L. ; Hill, Kevin P. ; Wasan, Ajay D. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2014;145:121-126. [doi: 10.1016/j.drugalcdep.2014.10.002].
 
19. Who Benefits from Additional Drug Counseling Among Prescription Opioid Dependent Patients Receiving Buprenorphine-Naloxone and Standard Medical Management? doc type
  Weiss, Roger D. ; Griffin, Margaret L. ; Potter, Jennifer Sharpe ; Dodd, Dorian R. ; Dreifuss, Jessica A. ; Connery, Hilary Smith ; Carroll, Kathleen M.
 Drug and Alcohol Dependence 2014;104(1):118-122. [doi: 10.1016/j.drugalcdep.2014.04.005].
 
20. Reasons for Opioid Use Among Patients with Dependence on Prescription Opioids: The Role of Chronic Pain. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; McHugh, R. Kathryn ; Haller, Deborah L. ; Jacobs, Petra ; Gardin, John G. II ; Fischer, Daniel ; Rosen, Kristen D.
 Journal of Substance Abuse Treatment 2014;47(2):140-145. [doi: 10.1016/j.jsat.2014.03.004].
 
21. Baseline Characteristics and Treatment Outcomes in Prescription Opioid Dependent Patients With and Without Co-Occurring Psychiatric Disorder. doc type
  Griffin, Margaret L. ; Dodd, Dorian R. ; Potter, Jennifer Sharpe ; Rice, Lindsay S. ; Dickinson, William ; Sparenborg, Steven ; Weiss, Roger D.
 American Journal of Drug and Alcohol Abuse 2014;40(2):157-162. [doi: 10.3109/00952990.2013.842241].
 
22. The Relationship Between Primary Prescription Opioid and Buprenorphine-Naloxone Induction Outcomes in a Prescription Opioid Dependent Sample. doc type
  Nielsen, Suzanne ; Hillhouse, Maureen ; Weiss, Roger D. ; Mooney, Larissa ; Potter, Jennifer Sharpe ; Lee, Joshua ; Gourevitch, Marc N. ; Ling, Walter
 American Journal on Addictions 2014;23(4):343-348. [doi: 10.1111/j.1521-0391.2013.12105.x].
 
23. Concurrent Substance Abuse is Associated with Sexual Risk Behavior Among Adults Seeking Treatment for Prescription Opioid Dependence. doc type
  Meade, Christina S. ; Bevilacqua, Lisa A. ; Moore, Elizabeth D. ; Griffin, Margaret L. ; Gardin, John G. II ; Potter, Jennifer Sharpe ; Hatch-Maillette, Mary A. ; Weiss, Roger D.
 American Journal on Addictions 2014;23(1):27-33. [doi: 10.1111/j.1521-0391.2013.12057.x].
 
24. Opioid Withdrawal and Craving Trajectories Following Buprenorphine Taper: A Latent Class and Growth Mixture Model of Time-to-First Opioid Lapse. doc type
  Northrup, Thomas F. ; Stotts, Angela L. ; Green, Charles ; Potter, Jennifer Sharpe ; Marino, Elise N. ; Weiss, Roger D. ; Mulpur, Swetha ; Walker, N. Robrina ; Trivedi, Madhukar H.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 15-20, 2013.
 
25. Medication-Assisted Treatment for Opioid Dependence & Barriers to Implementation. doc type
  Winstanley, Erin L.
 Presented at the Medication Assisted Treatment Conference, co-sponsored by the North Dakota Addiction Counselor Association and the Ohio Valley Node of the Clinical Trials Network, Jamestown, ND, April 25-26, 2013.
 
26. Patient Characteristics Associated with Buprenorphine/Naloxone Treatment Outcome for Prescription Opioid Dependence: Results from a Multisite Study. doc type
  Dreifuss, Jessica A. ; Griffin, Margaret L. ; Frost, Katherine ; Fitzmaurice, Garrett M. ; Potter, Jennifer Sharpe ; Fiellin, David A. ; Selzer, Jeffrey A. ; Hatch-Maillette, Mary A. ; Sonne, Susan C. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2013;131(1-2):112-118. [doi: 10.1016/j.drugalcdep.2012.12.010].
 
27. Gender Differences in a Clinical Trial for Prescription Opioid Dependence. doc type
  McHugh, R. Kathryn ; DeVito, Elise E. ; Dodd, Dorian ; Carroll, Kathleen M. ; Potter, Jennifer Sharpe ; Greenfield, Shelly F. ; Connery, Hilary Smith ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2013;45(1):38-43. [doi: 10.1016/j.jsat.2012.12.007].
 
28. Advances in Clinical Research for Prescription Opioid Dependence. doc type
  Provost, Scott E. ; Potter, Jennifer Sharpe ; Weiss, Roger D.
 Presented at the National Association of Social Workers Massachusetts Chapter Symposium, Framingham, MA, March 29-30, 2012.
 
29. Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-Phase Randomized Controlled Trial. doc type doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Fiellin, David A. ; Byrne, Mimmie ; Connery, Hilary Smith ; Dickinson, William ; Gardin, John G. II ; Griffin, Margaret L. ; Gourevitch, Marc N. ; Haller, Deborah L. ; Hasson, Albert L. ; Huang, Zhen ; Jacobs, Petra ; Kosinski, Andrzej S. ; Lindblad, Robert ; McCance-Katz, Elinore F. ; Provost, Scott E. ; Selzer, Jeffrey A. ; Somoza, Eugene C. ; Sonne, Susan C. ; Ling, Walter
 Archives of General Psychiatry 2011;68(12):1238-1246. [doi: 10.1001/archgenpsychiatry.2011.121].
 
30. Site Selection in Community-Based Clinical Trials for Substance Use Disorders: Strategies for Effective Site Selection. doc type
  Potter, Jennifer Sharpe ; Donovan, Dennis M. ; Weiss, Roger D. ; Gardin, John G. II ; Lindblad, Robert ; Wakim, Paul G. ; Dodd, Dorian R.
 American Journal of Drug and Alcohol Abuse 2011;37(5):400-407. [doi: 10.3109/00952990.2011.596975].
 
31. Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction Treatment Study. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; Connery, Hilary Smith ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Hollywood, FL, June 18-23, 2011.
 
32. The National Drug Abuse Treatment Clinical Trials Network: Forging a Partnership between Research Knowledge and Community Practice. doc type
  Tai, Betty ; Sparenborg, Steven ; Liu, David S. ; Straus, Michele M.
 Substance Abuse and Rehabilitation 2011;2:21-28. [doi: 10.2147/SAR.S16756].
 
33. What the National Institute on Drug Abuse's Clinical Trials Network Can Do For You? Major Findings from Medication Trials and Implications for Community-Based Settings. doc type
  Weiss, Roger D.
 Presented at the NIATx Summit and State Associations of Addiction Services (SAAS) National Conference, Boston, MA, July 19-22, 2011.
 
34. A Community-Based, Two-Phase Randomized Controlled Trial of Buprenorphine With and Without Individual Drug Counseling for the Treatment of Opioid Analgesic Addiction. doc type
  Provost, Scott E. ; Potter, Jennifer Sharpe ; Weiss, Roger D. ; Jacobs, Petra ; Ling, Walter
 Poster presented at the American Public Health Association (APHA) Annual Meeting, Denver, CO, November 6-10, 2010..
 
35. Alterations in Brain Structure and Functional Connectivity in Prescription Opioid-Dependent Patients. doc type
  Upadhyay, Jaymin ; Maleki, Nasim ; Potter, Jennifer Sharpe ; Elman, Igor ; Rudrauf, David ; Knudsen, Jaime ; Wallin, Diane ; Pendse, Gautam ; McDonald, Leah ; Griffin, Margaret L. ; Anderson, Julie ; Nutile, Lauren ; Renshaw, Perry ; Weiss, Roger D. ; Becerra, Lino ; Borsook, David
 Brain 2010;133(7):2098-2114. [doi: 10.1093/brain/awq138].
 
36. Ten Years of Pharmacotherapy Trials in the CTN: An Overview. doc type
  Brady, Kathleen T.
 Presented at the CTN 10th Anniversary Symposium, Albuquerque, NM, April 21, 2010.
 
37. From Research to the Real World: Buprenorphine in the Decade of the Clinical Trials Network. doc type
  Ling, Walter ; Jacobs, Petra ; Hillhouse, Maureen P. ; Hasson, Albert L. ; Thomas, Christie ; Freese, Thomas E. ; Sparenborg, Steven ; McCarty, Dennis ; Weiss, Roger D. ; Saxon, Andrew J. ; Cohen, Allan J. ; Straus, Michele M. ; Brigham, Gregory S. ; Liu, David S. ; McLaughlin, Paul ; Tai, Betty
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S53-S60. [doi: 10.1016/j.jsat.2010.01.009].
 
38. A Method to Diagnose Opioid Dependence Resulting from Heroin Versus Prescription Opioids Using the Composite International Diagnostic Interview. doc type
  Potter, Jennifer Sharpe ; Prather, Kristi ; Kropp, Frankie B. ; Byrne, Mimmie ; Sullivan, Carl Rollynn ; Mohamedi, Nadia ; Copersino, Marc L. ; Weiss, Roger D.
 Contemporary Clinical Trials 2010;31(2):185-188. [doi: 10.1016/j.cct.2010.01.002].
 
39. Conducting Clinical Research with Prescription Opioid Dependence: Defining the Population. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Copersino, Marc L. ; Prather, Kristi ; Jacobs, Petra ; Provost, Scott E. ; Chim, David ; Selzer, Jeffrey A. ; Ling, Walter
 American Journal on Addictions 2010;19(2):141-146. [doi: 10.1111/j.1521-0391.2009.00017.x].
 
40. A Multi-Site, Two-Phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, Design, and Methodology. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Provost, Scott E. ; Huang, Zhen ; Jacobs, Petra ; Hasson, Albert L. ; Lindblad, Robert ; Connery, Hilary Smith ; Prather, Kristi ; Ling, Walter
 Contemporary Clinical Trials 2010;31(2):189-199. [doi: 10.1016/j.cct.2010.01.003].
 
41. Use of an Adaptive Treatment Research Design in a CTN Study of Prescription Opioid Dependence Treatment. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Byrne, Mimmie ; Sullivan, Carl Rollynn ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Reno/Sparks, Nevada, June 20-25, 2009.
 
42. Using a Standardized Patient Walk-Through to Improve Implementation of Clinical Trials. doc type
  Fussell, Holly E. ; Kunkel, Lynn E. ; Lewy, Colleen S. ; McFarland, Bentson H. ; McCarty, Dennis
 Journal of Substance Abuse Treatment 2008;35(4):470-475. [doi: 10.1016/j.jsat.2008.03.001].
 
43. Integrating Services Research into CTN Clinical Trials: The Synergy is in the Details. doc type
  Perl, Harold I.
 Presented at the Addiction Health Services Research Conference, October 15-17, 2007, Athens, GA.
 
44. Using Standardized Patients to Pilot Screening Visits in Clinical Trials. doc type
  Kunkel, Lynn E. ; Fussell, Holly E. ; Shannon-Lewy, Colleen ; McFarland, Bentson H.
 Poster presented at the Society for Clinical Trials Annual Meeting, Montreal, Canada, May 20-23, 2007.
 
45. Prescription Opioid Addiction Treatment Study: Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 

New Search